期刊文献+

ERK5在结直肠癌组织中的表达及其与结直肠癌转移的关系 被引量:5

Expression of ERK5 in colorectal cancer tissues and its correlation with distant metastasis in colorectal cancer patients
下载PDF
导出
摘要 目的:检测和分析细胞外信号调节激酶5(ERK5)蛋白在原发性结直肠癌组织和癌旁正常黏膜组织中的表达情况及其与结直肠癌临床病理参数的关系,探讨ERK5的临床意义。方法:使用组织芯片和免疫组化的方法检测338例原发性结直肠癌癌组织和80例癌旁正常组织中ERK5的表达,分析ERK5表达与结直肠癌的临床病理参数及预后的相关性。结果:80例癌旁正常黏膜中,ERK5低表达59例(73.8%)、高表达为21例(26.2%);338例结直肠癌组织中ERK5低表达204例(60.4%)、高表达134例(39.6%);二者中的ERK5蛋白表达有显著差异(P<0.05)。在338例结直肠癌组织中,27例发生远处转移患者的癌组织中ERK5高表达率为63.0%,而311例未发生远处转移患者的癌组织中ERK5高表达率为37.6%,二者之间有显著差异(P<0.05)。但癌组织中ERK5的表达水平与患者性别、年龄、体重指数、肿瘤位置、T分期、N分期、TNM分期和分化程度无明显相关性(P>0.05)。Kaplan-Meier生存分析显示在结直肠癌组织中ERK5高表达的病人总体5年生存率与低表达组无明显差异(P>0.05)。结论:ERK5蛋白在癌组织中的表达较癌旁正常组织高;发生远处转移的结直肠癌组织中ERK5蛋白的表达水平明显高于未发生远处转移的癌组织中ERK5水平。ERK5可能是一个促进肿瘤远处转移的因子。 AIM: To investigate the expression of extraceUular signal - regulated kinase 5 ( ERK5 ) in primary coloreetal cancer (CRC) and adjacent normal mucesa, and to analyze the relationship between ERK5 expression and clini- copathological parameters for exploring the functions of ERK5 in the occurrence and development of CRC. METHODS: The expression of ERK5 in carcinoma tissues and normal mueosa was examined by a set of tissue mieroarrays and the meth- od of immunohistochemistry. The potential relationship between ERK5 expression and elinieopathologieal features was also analyzed. RESULTS: ERK5 expression was significantly higher in CRC tissues ( 134/338, 39. 6% ) than that in normal tissues (21/80, 26. 2% ; P 〈 0. 05 ). Overexpression of ERK5 in CRC tissues was significantly correlated with distant me- tastasis (P 〈 0. 05 ). However, no correlation between ERK5 expression and age at surgery, sex, tumor location, the depth of invasion, lymph node metastasis, TNM staging or differentiation grade was found (P 〉 0. 05 ). According to the Kaplan - Meier analysis, there is no significant difference in 5 - year overall survival between the patients with ERK5 expression at high level and at low level. CONCLUSION: ERK5 protein is highly expressed in CRC with distant metastasis. This may be a promotive factor in the process of distant metastasis.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2012年第7期1213-1218,共6页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.81172040)
关键词 细胞外信号调节激酶5 结直肠肿瘤 肿瘤转移 Extracellular signal - regulated kinase 5 Coloreetal neoplasms Neoplasm metastasis
  • 相关文献

参考文献24

  • 1Jemai A, Bray F, Center MM, et al. Global cancer statis- tics[J]. CA Cancer J Clin,2011,61(2) :69 -90.
  • 2张思维,雷正龙,李光琳,邹小农,赵平,陈万青.中国肿瘤登记地区2006年肿瘤发病和死亡资料分析[J].中国肿瘤,2010,19(6):356-365. 被引量:193
  • 3Siegel R, Ward E, Brawley O, et al. Cancer statistics,2011: the impact ofdiminating disparities on premature cancer deaths [ J ] Clin,2011,61 (4) :212 - 236.
  • 4Paschos KA, Bird N. Current diagnostic and therapeutic approaches for eolorectal cancer liver metastasis [J]. Hip- pokratia,2008,12(3) :132 - 138.
  • 5Wang X, Toumier C. Regulation of cellular functions by the ERK5 signalling pathway [ J]. Cell Signal, 2006, 18 (6) :753 -760.
  • 6Hayashi M, Kim SW, Imanaka - Yoshida K, et al. Targe- ted deletion of BMK1/ERK5 in adult mice perturbs vascu- 1ar integrity and leads to endothelial failure[ J]. J Clin In- vest,2004,113 (8) :1138 -1148.
  • 7Hayashi M, Fearns C, Eliceiri B, et al. Big mitogen - ac- tivated protein kinase 1/extracellular signal -regulated ki- nase 5 signaling pathway is essential for tumor - associated angiogenesis [ J ]. Cancer Res, 2005,65 ( 17 ) : 7699 - 7706.
  • 8Mccracken SR, Ramsay A, Heer R, et al. Aberrant ex- pression of extraceUular signal - regulated kinase 5 in hu- man prostate cancer [ J ]. Oncogene, 2008,27 ( 21 ) : 2978 - 2988.
  • 9Montero JC, Ocafia A, Abad M, et al. Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target[J]. PLoS 0ne,2009,4(5) :e5565.
  • 10Sticht C, Freier K, Knopfle K, et al. Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC) [ J ]. Neoplasia, 2008,10 (5) :462 - 470.

二级参考文献25

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I : comparability, validity and timeliness [J]. Eur J Cancer, 2009, 45: 747-755.
  • 3Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, Vol. IX. IARC scientific: publications No. 160[M], Lyon: IARC, 2007.
  • 4Parkin DM, Chen VM, Ferlay J, et al. Comparability and quality control in cancer registration. IARC technical report No.19[M]. Lyon: IARC, 1994.
  • 5Felay J, Bnrkhard C, Whelan S, et al. Check and conversion programs for cancerregistries. IARC Technical Report No. 42[M]. Lyon: IARC, 2005.
  • 6Felay J. The IARCcrgTools program [EB/OL]. http://www.iacr.com.fr/iarccrgtools.htm, 2006.
  • 7赵平,陈万青.2008年中国肿瘤登记年报[M].第1版.北京:军事医学科学出版社,2009.88-89.
  • 8全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 9Sourvinos G,Tsatsanis C,Spandidos DA.Overexpressionof theTpl-2/Cotoncogene in human breast cancer. Oncegene . 1999
  • 10Ohara R,Hirota S,Onoue H,et al.Identification of thecells expressingcotproto-oncogene mRNA. Journal of Cell Science . 1995

共引文献194

同被引文献37

  • 1蔡瑞霞,盛霞,袁志浩,叶增强.CD105、COX-2和VEGF在结直肠癌中的表达及其与血管新生的关系[J].肿瘤防治研究,2007,34(2):125-127. 被引量:21
  • 2Johnson GL, Lapadat R. Mitogen - activated protein ki- nase pathways mediated by ERK,JNK and p38 protein kinases [ J ]. Science, 2002,298 (5600) : 1911 - 1912.
  • 3Wang X, Tournier C. Regulation of cellular functions by the ERIC5 signalling pathway [ J ]. Cell Signal, 2006,18 ( 6 ) : 753- 60.
  • 4Sun W, Kesavan K, Schaefer BC, et al. MEKK2 associ- ates with the adapter protein Lad/RIBP and regulates the MEK5/BMK1/ERK5 pathway[ J]. J Biol Chem,2001,276 :5093 -100.
  • 5Ebisuya M, Kondon K, NishidaE. The duration magni- tude and compartmentalization of ERK MAPK kinase activity: mechanisms of Providing signaling specificity [ J ]. J Cell Sci, 2005,118 : 2997 - 3002.
  • 6Wang X, Tournier C. Regulation of cellular functions bythe ERK5 signalling pathway [ J ]. Cell Signal, 2006,18 ( 6 ) : 753 - 760.
  • 7Sticht C, Freier K, Knopfle K, et al. Activation of MAP kinase signaling through ERK5 but not ERK1 expression is asso- ciated with lymph node metastases in oral squamous cell carcino- ma( OSCC ) [ J ]. Neoplasia ,2008,10 ( 5 ) :462 - 470.
  • 8Montero JC, Ocaa A, Abad M, et al. Expression of Erk5 in early stage breast cancer and association with disease free sur- vival identifies this kinase as a potential therapeutic target [ J]. PLoS One ,2009,4 ( 5 ) : e5565.
  • 9Mccracken SR, Ramsay A, Heer R, et al. Aberrant ex- pression of extracellular signal regulated kinase 5 in human pros-tate cancer[ J ]. Oncogene ,2008,27 ( 21 ) :2978 - 2988.
  • 10Ramos - Nino ME, Blumen SR, Sabo - Attwood T, et al. HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra - 1 pathway [ J ]. Am J Respir Cell Mol Biol,2008,38(2) :209 -217.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部